Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 25.82
+0.38 (1.49%)
Apr 8, 2026, 3:00 PM CST
Guobang Pharma Revenue
In the year 2025, Guobang Pharma had annual revenue of 6.01B CNY with 2.05% growth. Guobang Pharma had revenue of 1.54B in the quarter ending December 31, 2025, with 4.67% growth.
Revenue
6.01B
Revenue Growth
+2.05%
P/S Ratio
2.38
Revenue / Employee
1.50M
Employees
4,003
Market Cap
14.28B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.01B | 120.56M | 2.05% |
| Dec 31, 2024 | 5.89B | 541.39M | 10.12% |
| Dec 31, 2023 | 5.35B | -371.48M | -6.49% |
| Dec 31, 2022 | 5.72B | 1.22B | 26.98% |
| Dec 31, 2021 | 4.51B | 299.03M | 7.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition